Skip to search boxSkip to navigationSkip to main content

Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores

  • the 23andMe Research Team
    ,
  • Global Parkinson’s Genetics Program (GP2)
    ,
  • Paula Saffie-Awad(Author)
    ,
  • Spencer M. Grant(Author)
    ,
  • Mary B. Makarious(Author)
    ,
  • Inas Elsayed(Author)
  • Clínica Santa María
    ,
  • Federal University of Rio Grande do Sul
    ,
  • Avenida José Joaquín Prieto Vial #7271
    ,
  • National Institute on Aging (NIA)
    ,
  • UCL Queen Square Institute of Neurology
    ,
  • University of Gezira
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

201

Journal (Volume, Issue Number)

npj Parkinson's Disease (Volume 11, Issue 1)

Publication milestones

  • Published - 12/2025

Publication status

Published - 12/2025

Publication IDs

  • Scopus: 105012492428

Abstract

Risk prediction models play a crucial role in advancing healthcare by enabling early detection and supporting personalized medicine. Nonetheless, polygenic risk scores (PRS) for Parkinson’s disease (PD) have not been extensively studied across diverse populations, contributing to health disparities. In this study, we constructed 105 PRS using individual-level data from seven ancestries and compared two different models. Model 1 was based on the cumulative effect of 90 known European PD risk variants, weighted by summary statistics from four independent ancestries (European, East Asian, Latino/Admixed American, and African/Admixed). Model 2 leveraged multi-ancestry summary statistics using a p-value thresholding approach to improve prediction across diverse populations. Our findings provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk prediction. We observed variability in predictive performance between models, underscoring the need for larger sample sizes and ancestry-specific approaches to enhance accuracy. These results establish a foundation for future research aimed at improving generalizability in genetic risk prediction for PD.